Stay updated on PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Sign up to get notified when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.4, indicating deployment of a new page version that replaces the previous v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-15T14:34:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
     ClinicalTrials.gov’s study page revision label was updated to a newer version (v3.5.3) from the previous one (v3.5.2).
    Difference
    0.1%
    Check dated 2026-04-24T05:46:46.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:05.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    - Cosmetic UI adjustments observed (overlay elements and layout tweaks). Core study content such as eligibility criteria, interventions, and primary outcomes remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T11:37:37.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.5.0' was added and the previous label 'Revision: v3.4.3' was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:37.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3 (v3.4.2 removed) on the page footer.
    Difference
    0.1%
    Check dated 2026-03-12T00:27:41.000Z thumbnail image

Stay in the know with updates to PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.